Source:http://linkedlifedata.com/resource/pubmed/id/20054616
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2010-4-16
|
pubmed:abstractText |
Sprouty1 (Spry1) is a conserved antagonist of FGF signaling. The goal of this study was to further explore the downstream mechanisms governing Spry1 inhibition of endothelial cell proliferation. Up-regulation of Spry1 in HUVECs inhibited tube formation on Matrigel (n = 6, P < 0.001). This was associated with decreased proliferation as measured by BrdU incorporation (n = 6, P < 0.001) and increased protein expression of the cyclin-dependent kinase inhibitor 1A (CDKN1A), p21 and cyclin-dependent kinase inhibitor 1B (CDKN1B), p27. A transcriptional analysis using a targeted human angiogenesis array following up-regulation of Spry1 demonstrated a >2-fold increase in an anti-angiogenic factor, serpin peptidase inhibitor, clad F (Serpinf1), and a >2-fold decrease in pro-angiogenic factors fms-related tyrosine kinase 1 (FLT1), angiopoietin2 (Ang-2), and placental growth factor (PGF) (n = 2). To define upstream mechanisms that may regulate endogenous Spry1, we performed a search for responsive elements upstream of the promoter region. This search resulted in the identification of multiple degenerate hypoxia responsive elements. Exposure to hypoxia resulted in a significant increase in Spry1 expression (n = 8, P < 0.01). These findings shed new light on downstream signaling pathways associated with Spry1 anti-proliferative responses, and provide new evidence that hypoxia stimulates Spry1 expression.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor...,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor...,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/SPRY1 protein, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1573-4919
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
338
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
255-61
|
pubmed:meshHeading |
pubmed-meshheading:20054616-Anoxia,
pubmed-meshheading:20054616-Cell Proliferation,
pubmed-meshheading:20054616-Cells, Cultured,
pubmed-meshheading:20054616-Cyclin-Dependent Kinase Inhibitor p21,
pubmed-meshheading:20054616-Cyclin-Dependent Kinase Inhibitor p27,
pubmed-meshheading:20054616-Endothelial Cells,
pubmed-meshheading:20054616-Humans,
pubmed-meshheading:20054616-Membrane Proteins,
pubmed-meshheading:20054616-Neovascularization, Physiologic,
pubmed-meshheading:20054616-Phosphoproteins,
pubmed-meshheading:20054616-Promoter Regions, Genetic,
pubmed-meshheading:20054616-RNA, Messenger,
pubmed-meshheading:20054616-Signal Transduction,
pubmed-meshheading:20054616-Up-Regulation
|
pubmed:year |
2010
|
pubmed:articleTitle |
Sprouty1 inhibits angiogenesis in association with up-regulation of p21 and p27.
|
pubmed:affiliation |
Lillehei Heart Institute, University of Minnesota, Minneapolis, MN, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|